ebomi
Colour theme
Sign in
Insider · CIK 0001402856

McGaughy R Kent Jr

CIK 0001402856 Name as filed on the most recent filing

Filed as McGaughy R Kent Jr (20)

49 transaction lines · from 20 filings · filed 2016-06-01 to 2021-10-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

48 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-10-15 P, Open-market purchase Apollo Endosurgery, Inc.APEN 3 lines 5,300,000, acquired Open Form 4 filing 0001140361-21-034925
2021-09-17 P, Open-market purchase Procept BioRobotics CorpPRCT 11,000,000, acquired Open Form 4 filing 0001628280-21-018953
2021-03-23 P, Open-market purchase Instil Bio, Inc.TIL 9,000,000, acquired Open Form 4 filing 0001209191-21-023063
2020-07-17 P, Open-market purchase Apollo Endosurgery, Inc.APEN 3 lines 2,225,000, acquired Open Form 4 filing 0000905148-20-000826
2019-11-18 P, Open-market purchase Reata Pharmaceuticals IncRETA 7,359,894, acquired Open Form 4 filing 0000905148-19-001002
2018-12-12 P, Open-market purchase Reata Pharmaceuticals IncRETA 84,931, acquired Open Form 4 filing 0000905148-18-000921
2018-12-11 P, Open-market purchase Reata Pharmaceuticals IncRETA 3,172,337, acquired Open Form 4 filing 0000905148-18-000921
2018-12-10 P, Open-market purchase Reata Pharmaceuticals IncRETA 3 lines 3,326,566, acquired Open Form 4 filing 0000905148-18-000921
2017-12-29 P, Open-market purchase Reata Pharmaceuticals IncRETA 484,016, acquired Open Form 4 filing 0001140361-17-047823
2017-12-28 P, Open-market purchase Reata Pharmaceuticals IncRETA 5,220, acquired Open Form 4 filing 0001140361-17-047649
2017-12-27 P, Open-market purchase Reata Pharmaceuticals IncRETA 387,444, acquired Open Form 4 filing 0001140361-17-047649
2017-12-26 P, Open-market purchase Reata Pharmaceuticals IncRETA 312,726, acquired Open Form 4 filing 0001140361-17-047649
2017-12-14 P, Open-market purchase Reata Pharmaceuticals IncRETA 1,929,698, acquired Open Form 4 filing 0000905148-17-000940
2017-12-13 P, Open-market purchase Reata Pharmaceuticals IncRETA 2 lines 3,028,708, acquired Open Form 4 filing 0000905148-17-000940
2017-07-25 P, Open-market purchase Apollo Endosurgery, Inc.APEN 5 lines 2,499,998, acquired Open Form 4 filing 0001179110-17-010716
2016-12-30 P, Open-market purchase Reata Pharmaceuticals IncRETA 204,038, acquired Open Form 4 filing 0000905148-17-000017
2016-12-16 P, Open-market purchase Reata Pharmaceuticals IncRETA 3,787,820, acquired Open Form 4 filing 0000905148-16-002140
2016-12-15 P, Open-market purchase Reata Pharmaceuticals IncRETA 59,534, acquired Open Form 4 filing 0000905148-16-002130
2016-12-14 P, Open-market purchase Reata Pharmaceuticals IncRETA 132,229, acquired Open Form 4 filing 0000905148-16-002130
2016-08-18 P, Open-market purchase Reata Pharmaceuticals IncRETA 1,828,651, acquired Open Form 4 filing 0000905148-16-001850
2016-08-17 P, Open-market purchase Reata Pharmaceuticals IncRETA 2,486,816, acquired Open Form 4 filing 0000905148-16-001850
2016-08-16 P, Open-market purchase Reata Pharmaceuticals IncRETA 949,953, acquired Open Form 4 filing 0000905148-16-001850
2016-06-30 P, Open-market purchase Reata Pharmaceuticals IncRETA 1,975,110, acquired Open Form 4 filing 0000905148-16-001717
2016-06-29 P, Open-market purchase Reata Pharmaceuticals IncRETA 1,263,056, acquired Open Form 4 filing 0000905148-16-001717
2016-06-28 P, Open-market purchase Reata Pharmaceuticals IncRETA 17,763, acquired Open Form 4 filing 0000905148-16-001717
2016-06-27 P, Open-market purchase Reata Pharmaceuticals IncRETA 421,234, acquired Open Form 4 filing 0000905148-16-001704
2016-06-24 P, Open-market purchase Reata Pharmaceuticals IncRETA 2 lines 992,334, acquired Open Form 4 filing 0000905148-16-001704
2016-06-07 P, Open-market purchase Reata Pharmaceuticals IncRETA 74,360, acquired Open Form 4 filing 0000905148-16-001666
2016-06-06 P, Open-market purchase Reata Pharmaceuticals IncRETA 351,192, acquired Open Form 4 filing 0000905148-16-001666
2016-06-01 P, Open-market purchase Reata Pharmaceuticals IncRETA 8,822,000, acquired Open Form 4 filing 0000905148-16-001815
2016-06-01 P, Open-market purchase Reata Pharmaceuticals IncRETA 6 lines 3,194,224, acquired Open Form 4 filing 0001140361-16-068153
2016-06-01 P, Open-market purchase Reata Pharmaceuticals IncRETA 107,829, acquired Open Form 4 filing 0000905148-16-001653

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 48
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. McGaughy R Kent Jr, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001402856

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.